The Food and Drug Administration (FDA) has approved the combination of nivolumab (Opdivo ®) plus ipilimumab (Yervoy ® ), both from Bristol Myers Squibb Company, as an option for first-line therapy for ...

NAFLD is a silent liver threat affecting millions. An expert explains its link to diet, lifestyle, and rising liver cancer risk worldwide. Read on..., Health News - Times Now ...

Hepatocellular carcinoma (HCC), which accounts for up to 80% of cases of primary liver cancer, is typically diagnosed in an advanced stage, meaning a poor prognosis. Understanding what drives ...

Green tea reduces inflammation and improves healthy ageing, which are both significant in lowering the risk of liver diseases ...

According to studies, drinking the tea daily can decrease your risk of developing certain cancers, like liver cancer.

Given the success of Research Topic <a href=" and Prognostic Assessment of Liver Cirrhosis and Its Complications and the ...

Discover a study that has proposed a predictive model for cirrhosis and hepatocellular carcinoma in individuals with ...

In the field of immunology, innate lymphoid cells (ILCs) have emerged as significant players within the hepatobiliary and gastrointestinal systems.

Hepion’s primary asset, Rencofilstat, is a potent inhibitor of cyclophilins, which are involved in many disease processes. Rencofilstat has been sown to reduce liver fibrosis and hepatocellular ...

WCRF International. (2022, April 14). [4] Golabi P, Fazel S, Otgonsuren M, Sayiner M, Locklear CT, Younossi ZM. (2017). Mortality assessment of patients with hepatocellular carcinoma according to ...

Among patients with hepatocellular carcinoma, MAFLD was not an independent predictor for overall survival or progression-free survival.

People with coeliac disease have shared the most common symptoms they experienced which led to them getting a diagnosis. Coeliac disease is an autoimmune condition caused by a negative response to ...